ROYAL BANK OF CANADA - UROGEN PHARMA LTD ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$239,000
+42.3%
17,016
+4.7%
0.00%
Q2 2023$168,000
+14.3%
16,252
+2.7%
0.00%
Q1 2023$147,000
+11.4%
15,826
+6.3%
0.00%
Q4 2022$132,000
+6.5%
14,887
+0.0%
0.00%
Q3 2022$124,000
+1.6%
14,8820.0%0.00%
Q2 2022$122,000
-12.2%
14,882
-7.5%
0.00%
Q1 2022$139,000
-17.3%
16,080
-9.3%
0.00%
Q4 2021$168,000
-46.7%
17,726
-5.3%
0.00%
Q3 2021$315,000
+12.1%
18,726
+1.6%
0.00%
Q2 2021$281,000
-86.0%
18,428
-82.1%
0.00%
-100.0%
Q1 2021$2,011,000
+15.2%
103,215
+6.5%
0.00%0.0%
Q4 2020$1,746,000
-11.4%
96,904
-5.1%
0.00%0.0%
Q3 2020$1,970,000
-26.2%
102,119
-0.1%
0.00%0.0%
Q2 2020$2,669,000
+48.4%
102,197
+1.4%
0.00%0.0%
Q1 2020$1,799,000
-47.2%
100,813
-1.3%
0.00%0.0%
Q4 2019$3,409,000
+630.0%
102,143
+420.8%
0.00%
Q3 2019$467,000
-27.6%
19,611
+9.3%
0.00%
Q2 2019$645,000
+45.3%
17,939
+48.8%
0.00%
Q1 2019$444,000
+56.9%
12,058
+83.7%
0.00%
Q4 2018$283,000
-20.1%
6,563
-12.3%
0.00%
Q3 2018$354,000
+17.6%
7,483
+23.6%
0.00%
Q2 2018$301,000
+19.9%
6,056
+19.9%
0.00%
Q1 2018$251,000
+79.3%
5,052
+34.5%
0.00%
Q4 2017$140,000
+154.5%
3,755
+114.6%
0.00%
Q3 2017$55,0001,7500.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders